ATE218853T1 - Flüssige wässrige arzneimittel, die natriumalginat und kaliumhydrogencarbonat enthalten - Google Patents

Flüssige wässrige arzneimittel, die natriumalginat und kaliumhydrogencarbonat enthalten

Info

Publication number
ATE218853T1
ATE218853T1 AT96903090T AT96903090T ATE218853T1 AT E218853 T1 ATE218853 T1 AT E218853T1 AT 96903090 T AT96903090 T AT 96903090T AT 96903090 T AT96903090 T AT 96903090T AT E218853 T1 ATE218853 T1 AT E218853T1
Authority
AT
Austria
Prior art keywords
hydrogen carbonate
sodium alginate
potassium hydrogen
containing sodium
products containing
Prior art date
Application number
AT96903090T
Other languages
English (en)
Inventor
Paul Frederick Field
Original Assignee
Reckitt Benckiser Healthcare
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10770811&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE218853(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Reckitt Benckiser Healthcare filed Critical Reckitt Benckiser Healthcare
Application granted granted Critical
Publication of ATE218853T1 publication Critical patent/ATE218853T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0065Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/06Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/10Carbonates; Bicarbonates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT96903090T 1995-03-03 1996-02-16 Flüssige wässrige arzneimittel, die natriumalginat und kaliumhydrogencarbonat enthalten ATE218853T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9504599.3A GB9504599D0 (en) 1995-03-03 1995-03-03 Improvements in or relating to organic compositions
PCT/GB1996/000358 WO1996027368A1 (en) 1995-03-03 1996-02-16 Liquid aqueous pharmaceutical compositions comprising sodium alginate and potassium bicarbonate

Publications (1)

Publication Number Publication Date
ATE218853T1 true ATE218853T1 (de) 2002-06-15

Family

ID=10770811

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96903090T ATE218853T1 (de) 1995-03-03 1996-02-16 Flüssige wässrige arzneimittel, die natriumalginat und kaliumhydrogencarbonat enthalten

Country Status (21)

Country Link
US (1) US5681827A (de)
EP (1) EP0813407B1 (de)
JP (1) JPH11501044A (de)
KR (1) KR19980702689A (de)
CN (1) CN1123337C (de)
AR (1) AR004168A1 (de)
AT (1) ATE218853T1 (de)
AU (1) AU696480B2 (de)
BR (2) BR9607679A (de)
CZ (1) CZ289386B6 (de)
DE (1) DE69621785T2 (de)
ES (1) ES2174054T3 (de)
GB (1) GB9504599D0 (de)
HU (1) HUP9801414A3 (de)
NO (1) NO316207B1 (de)
NZ (1) NZ301749A (de)
PL (1) PL184245B1 (de)
PT (1) PT813407E (de)
TR (1) TR199700891T1 (de)
WO (1) WO1996027368A1 (de)
ZA (1) ZA961517B (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6099871A (en) * 1995-06-01 2000-08-08 Bristol-Myers Squibb Company Anti-regurgitation infant formula
US6395307B1 (en) * 1997-04-30 2002-05-28 Reckitt Benckiser (Uk) Limited Pourable alginate compositions
US6027715A (en) * 1998-03-02 2000-02-22 Pozuelo; Jose Composition and means for treating dry mouth
AU4759099A (en) * 1998-09-21 2000-03-23 Mcneil-Ppc, Inc. Heat stable antacid and antigas suspensions
JP3959192B2 (ja) * 1998-12-03 2007-08-15 株式会社大塚製薬工場 経管栄養食品
US6351665B1 (en) 1999-05-07 2002-02-26 Kenneth L Koch Method and apparatus for evaluating myoelectric signals and identifying artifact
GB2384986B (en) * 2002-02-12 2004-01-07 Reckitt Benckiser Healthcare Compositions for the treatment of disorders of the upper gastrointestinal tract
SE530184C2 (sv) * 2005-12-23 2008-03-18 Kjell Stenberg Bioadhesiv farmaceutisk filmkomposition innehållande lågviskösa alginater
AU2006340298B2 (en) * 2006-03-16 2012-10-04 Glycologic Limited Gastric raft composition comprising preferably processed starches for inducing satiety
CA2676058C (en) 2007-02-13 2017-02-07 S-Biotek Holding Aps Diet product comprising alginate
WO2008106646A2 (en) * 2007-03-01 2008-09-04 Introgen Therapeutics, Inc Methods and formulations for topical gene therapy
KR100930809B1 (ko) * 2008-02-13 2009-12-09 (주)포테이토밸리 레드킹밸리 감자의 생즙 또는 전분을 유효성분으로함유하는 위염, 위궤양 및 십이지장궤양 예방 및 치료용약학조성물
WO2010108494A1 (en) * 2009-03-25 2010-09-30 S-Biotek Holding Aps Dayspepsia treatment with alginate
KR20120108218A (ko) * 2011-03-23 2012-10-05 동아제약주식회사 위식도 역류질환 치료용 액상 타입 조성물
WO2013055251A1 (ru) * 2011-10-14 2013-04-18 Общество С Ограниченной Ответственностью "Цитонир" Пероральная фармацевтическая композиция для лечения воспалительных заболеваний желудочно-кишечного тракта
EP2806880B2 (de) * 2012-01-27 2020-04-22 Institute of Bioorganic Chemistry Pharmazeutische zusammensetzung als antireflux-medikament
US9636360B2 (en) * 2012-09-18 2017-05-02 pH Science Holdings, Inc Method and composition for treating gastro-esophageal disorders
KR102303835B1 (ko) * 2014-01-08 2021-09-16 영진약품 주식회사 수성의 유동성 액체 조성물 및 이의 제조방법

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1524740A (en) * 1976-11-09 1978-09-13 Reckitt & Colmann Prod Ltd Pharmaceutical compositions for use in the suppression of gastric reflux
US4869902A (en) * 1984-04-19 1989-09-26 Rorer Pharmaceutical Corporation Antacid composition
JPH0764737B2 (ja) * 1984-04-19 1995-07-12 ローヌ−プーラン ローラー インターナショナル (ホウルディングス) インコーポレイテッド 制酸組成物
GB8618847D0 (en) * 1986-08-01 1986-09-10 Smith Kline French Lab Pharmaceutical formulations
DK179687D0 (da) * 1987-04-08 1987-04-08 Farma Food As Praeparat
NL8902338A (nl) * 1988-09-20 1990-04-17 Glaxo Group Ltd Farmaceutische preparaten.

Also Published As

Publication number Publication date
HK1007957A1 (zh) 1999-04-30
DE69621785T2 (de) 2002-11-28
DE69621785D1 (de) 2002-07-18
HUP9801414A3 (en) 2001-04-28
NZ301749A (en) 1998-05-27
CZ289386B6 (cs) 2002-01-16
CN1123337C (zh) 2003-10-08
GB9504599D0 (en) 1995-04-26
PL184245B1 (pl) 2002-09-30
CZ274997A3 (cs) 1998-03-18
ES2174054T3 (es) 2002-11-01
US5681827A (en) 1997-10-28
WO1996027368A1 (en) 1996-09-12
EP0813407B1 (de) 2002-06-12
BR9607679A (pt) 1998-07-07
AU696480B2 (en) 1998-09-10
PL322044A1 (en) 1998-01-05
HUP9801414A2 (hu) 1999-01-28
MX9706661A (es) 1997-11-29
AU4724496A (en) 1996-09-23
ZA961517B (en) 1996-09-03
TR199700891T1 (xx) 1998-02-21
PT813407E (pt) 2002-10-31
CN1177292A (zh) 1998-03-25
NO316207B1 (no) 2003-12-29
AR004168A1 (es) 1998-11-04
KR19980702689A (ko) 1998-08-05
NO973964D0 (no) 1997-08-28
BR9607679B8 (pt) 2014-11-18
JPH11501044A (ja) 1999-01-26
EP0813407A1 (de) 1997-12-29
NO973964L (no) 1997-08-28

Similar Documents

Publication Publication Date Title
ATE218853T1 (de) Flüssige wässrige arzneimittel, die natriumalginat und kaliumhydrogencarbonat enthalten
HUP9901086A3 (en) Arylsulfonylaminobenzene derivatives, pharmaceutical compositions containing them and their use for producing pharmaceutical compositions
HUP9802300A3 (en) N-heteroaryl-pyridinesulfonamide derivatives, pharmaceutical compositions containing them, process for producing them and their use
AU5318596A (en) Skin care products containing anti-itching/anti-irritant age nts
ATE248594T1 (de) Irbesartanhaltiges arzneimittel
HUP9802694A3 (en) Benzamide derivatives, process for producing them and pharmaceutical compositions containing them
AU679663B2 (en) Dermatological or pharmaceutical composition, preparation process and use
AU5287496A (en) Acetamide derivatives, process for producing the same, and medicinal composition containing the same
AR011565A3 (es) Una composicion humectante, liquida y acuosa
HUP9800792A3 (en) Benzylpiperidines and piperazines, their use and pharmaceutical compositions containing the same
HU9502443D0 (en) Glycinamide derivatives, processes for their preparation and medicines containing them
HUP9802552A3 (en) Piperazino derivatives process for their preparation, pharmaceuticals containing the same and their use
IL138028A0 (en) Metalloproteinase inhibitors, pharmaceutical compositions containing them and their pharmaceutical use
HUP9600876A3 (en) Benzonitril- and -fluoride derivatives, pharmaceutical compositions containing them, process for producing them and their use
HUP9901685A3 (en) Colchicine derivatives, the use thereof and formulations containing them
HUP9700005A3 (en) 2-ureido-benzamide derivatives and pharmaceutical compositions containing them as active agent
HUP9801880A3 (en) Novel cryptophycins, their use and pharmaceutical compositions containing them
EP0823255A4 (de) Sucralfat enthaltendes arzneimittel
HUP9801766A3 (en) 6-carboxamido dihydropyran derivatives, process for producing them and medicaments containing the same
GB9617893D0 (en) New pharmaceutical derivatives, process for obtaining them and pharmaceutical compositions containing them
HU9501925D0 (en) Ortho-amine-substituted benzoyl-guanidine derivatives, process for producing them their pharmaceutical or diagnostical use, and pharmaceutical compositions containing them
DE3788195D1 (de) DIBENZ[b,e]OXEPINDERIVATE, SOWIE ARZNEIMITTEL, DIE DIESE ALS AKTIVE MITTEL ENTHALTEN.
ITTO940560A0 (it) Testa rullatrice per l'applicazione di capsule di sigillo su bottigliein genere.
HUP9800631A3 (en) 4-aminotetrahydrobenzisoxazole or -isothiazole derivatives, pharmaceutical compositions containing them and their use for the preparation of pharmaceutical compositions
HUP9801068A2 (hu) 1,2,3,4-Tetrahidro-2-naftil-amin-származékok, ezek előállítása és alkalmazása, valamint ilyen származékokat tartalmazó gyógyászati készítmények

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee